|
1
|
Jovin TG, Demchuk AM and Gupta R:
Pathophysiology of Acute Ischemic Stroke. Continuum (Minneap Minn).
14:28–45. 2008.
|
|
2
|
Eren E, Yilmaz N and Aydin O: High density
lipoprotein and it's dysfunction. Open Biochem J. 6:78–93.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shao B and Heinecke JW: HDL, lipid
peroxidation, and atherosclerosis. J Lipid Res. 50:599–601.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee SH, Kim HS, Park YM, Kwon HS, Yoon KH,
Han K and Kim MK: HDL-cholesterol, its variability, and the risk of
diabetes: A nationwide population-based study. J Clin Endocrinol
Metab. 104:5633–5641. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kosmas CE, Martinez I, Sourlas A, Bouza
KV, Campos FN, Torres V, Montan PD and Guzman E: High-density
lipoprotein (HDL) functionality and its relevance to
atherosclerotic cardiovascular disease. Drugs Context.
7(212525)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sini S, Deepa D, Harikrishnan S and
Jayakumari N: Evidence for an exclusive association of matrix
metalloproteinase-9 with dysfunctional high-density lipoprotein: A
novel finding. Atherosclerosis. 236:162–168. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sanossian N, Saver JL, Navab M and
Ovbiagele B: High-density lipoprotein cholesterol: An emerging
target for stroke treatment. Stroke. 38:1104–1109. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ansell BJ, Navab M, Hama S, Kamranpour N,
Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST and
Fogelman AM: Inflammatory/antiinflammatory properties of
high-density lipoprotein distinguish patients from control subjects
better than high-density lipoprotein cholesterol levels and are
favorably affected by simvastatin treatment. Circulation.
108:2751–2756. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kalani R, Krishnamoorthy S, Deepa D,
Gopala S, Prabhakaran D, Tirschwell D and Sylaja PN:
Apolipoproteins B and A1 in Ischemic Stroke Subtypes. J Stroke
Cerebrovasc Dis. 29(104670)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Krishnamoorthy S, Damayanthi D, Gopala S,
Paul R and Sylaja PN: High-sensitivity C-reactive protein and
lipoprotein-associated phospholipase A2 in predicting recurrence
and severity of stenosis in symptomatic intracranial
atherosclerotic disease. Curr Proteomics. 18:231–236. 2021.
|
|
11
|
Tang X, Mao L, Chen J, Zhang T, Weng S,
Guo X, Kuang J, Yu B and Peng D: High-sensitivity CRP may be a
marker of HDL dysfunction and remodeling in patients with acute
coronary syndrome. Sci Rep. 11(11444)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shahar E, Chambless LE, Rosamond WD,
Boland LL, Ballantyne CM, McGovern PG and Sharrett AR:
Atherosclerosis Risk in Communities Study. Plasma lipid profile and
incident ischemic stroke: the Atherosclerosis Risk in Communities
(ARIC) study. Stroke. 34:623–631. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Y, Tuomilehto J, Jousilahti P, Wang
Y, Antikainen R and Hu G: Total and high-density lipoprotein
cholesterol and stroke risk. Stroke. 43:1768–1774. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Woodward M, Barzi F, Feigin V, Gu D,
Huxley R, Nakamura K, Patel A, Ho S and Jamrozik K: Asia Pacific
Cohort Studies Collaboration. Associations between high-density
lipoprotein cholesterol and both stroke and coronary heart disease
in the Asia Pacific region. Eur Heart J. 28:2653–2660.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Amarenco P, Labreuche J and Touboul PJ:
High-density lipoprotein-cholesterol and risk of stroke and carotid
atherosclerosis: A systematic review. Atherosclerosis. 196:489–496.
2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sacco RL, Benson RT, Kargman DE,
Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S and
Berglund L: High-density lipoprotein cholesterol and ischemic
stroke in the elderly: The northern Manhattan stroke study. JAMA.
285:2729–2735. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ortiz-Munoz G, Couret D, Lapergue B,
Bruckert E, Meseguer E, Amarenco P and Meilhac O: Dysfunctional HDL
in acute stroke. Atherosclerosis. 253:75–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Varela LM, Meseguer E, Lapergue B, Couret
D, Amarenco P and Meilhac O: Changes in high-density lipoproteins
related to outcomes in patients with acute stroke. J Clin Med.
9(2269)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Adams HP Jr, Bendixen BH, Kappelle LJ,
Biller J, Love BB, Gordon DL and Marsh EE III: Classification of
subtype of acute ischemic stroke. Definitions for use in a
multicenter clinical trial. TOAST. Trial of Org 10172 in acute
stroke treatment. Stroke. 24:35–41. 1993.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rankin J: Cerebral vascular accidents in
patients over the age of 60: II. Prognosis. Scott Med J. 2:200–215.
1957.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Femlak M, Gluba-Brzózka A, Ciałkowska-Rysz
A and Rysz J: The role and function of HDL in patients with
diabetes mellitus and the related cardiovascular risk. Lipids
Health Dis. 16(207)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Izzo C, Grillo F and Murador E: Improved
method for determination of high-density-lipoprotein cholesterol I.
Isolation of high-density lipoproteins by use of polyethylene
glycol 6000. Clin Chem. 27:371–374. 1981.PubMed/NCBI
|
|
23
|
Chapman MJ, Goldstein S, Lagrange D and
Laplaud PM: A density gradient ultracentrifugal procedure for the
isolation of the major lipoprotein classes from human serum. J
Lipid Res. 22:339–358. 1981.PubMed/NCBI
|
|
24
|
Navab M, Yu R, Gharavi N, Huang W, Ezra N,
Lotfizadeh A, Anantharamaiah GM, Alipour N, Van Lenten BJ, Reddy ST
and Marelli D: High-density lipoprotein: Antioxidant and
anti-inflammatory properties. Curr Atheroscler Rep. 9:244–248.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yin F, Ramanathan G, Zhang M and Araujo
JA: Prooxidative effects of ambient pollutant chemicals are
inhibited by HDL. J Biochem Mol Toxicol. 27:172–183.
2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Breton CV, Yin F, Wang X, Avol E,
Gilliland FD and Araujo JA: HDL anti-oxidant function associates
with LDL level in young adults. Atherosclerosis. 232:165–170.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Singh K, Chandra A, Sperry T, Joshi PH,
Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen
EG, et al: Associations between high-density lipoprotein particles
and Ischemic events by vascular domain, sex, and ethnicity: A
pooled cohort analysis. Circulation. 142:657–669. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Duparc T, Ruidavets JB, Genoux A,
Ingueneau C, Najib S, Ferrières J, Perret B and Martinez LO: Serum
level of HDL particles are independently associated with long-term
prognosis in patients with coronary artery disease: The GENES
study. Sci Rep. 10(8138)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sini S and Jayakumari N: Functionally
defective high density lipoprotein is pro-oxidant: A deviation from
normal atheroprotective character. Int J Nutr Food Sci. 2:92–101.
2013.
|
|
31
|
Feingold KR and Grunfeld C: Effect of
inflammation on HDL structure and function. Curr Opin Lipidol.
27:521–530. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lapergue B, Moreno JA, Dang BQ, Coutard M,
Delbosc S, Raphaeli G, Auge N, Klein I, Mazighi M, Michel JB, et
al: Protective effect of high-density lipoprotein-based therapy in
a model of embolic stroke. Stroke. 41:1536–1542. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kaul S, Alladi S, Jabeen SA, Bandaru
VCSSR, Ankem U, Mekala S and Naik GS: Intracranial atherosclerosis
is the most common stroke subtype: Ten-year data from Hyderabad
stroke registry (India). Ann Indian Acad Neurol. 21:209–213.
2018.PubMed/NCBI View Article : Google Scholar
|
